Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
148 * !
|
Mon, 7/29/2019,
10:30 AM -
12:20 PM
|
CC-201
|
|
Statistical Methods, Challenges and Impacts on Early Phase Trials — Invited Papers
|
|
ENAR, Biopharmaceutical Section, Statistics in Biopharmaceutical Research Journal
|
|
Organizer(s): Yu Du, Eli Lilly and Company
|
|
Chair(s): Pandurang Kulkarni, Eli Lilly & Company
|
|
10:35 AM
|
Model-Based Phase I Designs for Immuno-Oncology
Jun Yin, Mayo Clinic; Yu Du, Eli Lilly and Company; Sumithra Mandrekar, Mayo Clinic
|
|
10:55 AM
|
The Use of Bayesian Basket Design in Early Phase Trials
Shiling Ruan, Novartis; Matt Whiley, Novartis
|
|
11:15 AM
|
Advancing Pharmacogenomics Analysis of Drug Response in Early-Phase Clinical Trials
Judong Shen, Merck & Co., Inc.; Hong Zhang, Merck & Co., Inc.; Devan Mehrotra, Merck & Co., Inc
|
|
11:35 AM
|
Revolutionizing the Early Drug Development
Yongming Qu, Eli Lilly and Company
|
|
11:55 AM
|
Discussant: Ying Yuan, University of Texas M.D. Anderson Cancer Center
|
|
12:15 PM
|
Floor Discussion
|
|
